PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.63%
Negative revenue growth while AVGO stands at 1.42%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-0.43%
Negative gross profit growth while AVGO is at 3.55%. Joel Greenblatt would examine cost competitiveness or demand decline.
-2.53%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.40%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
9.72%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
10.53%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.71%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.21%
Share reduction while AVGO is at 0.25%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.53%
Reduced diluted shares while AVGO is at 0.96%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.21%
Dividend growth under 50% of AVGO's 29.84%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-51.48%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-56.63%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
37.56%
10Y revenue/share CAGR under 50% of AVGO's 661.75%. Michael Burry would suspect a lasting competitive disadvantage.
18.56%
5Y revenue/share CAGR under 50% of AVGO's 129.56%. Michael Burry would suspect a significant competitive gap or product weakness.
4.90%
3Y revenue/share CAGR under 50% of AVGO's 41.89%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
58.74%
10Y OCF/share CAGR under 50% of AVGO's 3258.21%. Michael Burry would worry about a persistent underperformance in cash creation.
56.76%
Below 50% of AVGO's 209.30%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
14.75%
3Y OCF/share CAGR under 50% of AVGO's 72.05%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
136.30%
Below 50% of AVGO's 500.77%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
100.76%
Positive 5Y CAGR while AVGO is negative. John Neff might view this as a strong mid-term relative advantage.
26.23%
Below 50% of AVGO's 61.49%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
4.46%
Below 50% of AVGO's 1230.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-16.33%
Negative 5Y equity/share growth while AVGO is at 330.83%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-22.07%
Negative 3Y equity/share growth while AVGO is at 28.50%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
647.52%
Dividend/share CAGR of 647.52% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
165.01%
Below 50% of AVGO's 887.69%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
80.30%
Below 50% of AVGO's 219.13%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
22.53%
AR growth well above AVGO's 12.03%. Michael Burry fears inflated revenue or higher default risk in the near future.
0.10%
Inventory shrinking or stable vs. AVGO's 8.01%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-4.08%
Negative asset growth while AVGO invests at 20.02%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-12.98%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
6.76%
Debt shrinking faster vs. AVGO's 36.34%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-2.33%
Our R&D shrinks while AVGO invests at 9.52%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.21%
SG&A declining or stable vs. AVGO's 46.94%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.